Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Single-Molecule Array (Simoa) Technology as a Highly Sensitive Screening Tool for Protein-Protein Interactions.

Created on 27 Oct 2025

Authors

Youngshin Lim, Maia Norman, Connie Chen, Il-Taeg Cho, David R Walt, Ginam Cho, Jeffrey A Golden

Published in

ACS sensors. Oct 27, 2025. Epub Oct 27, 2025.

Abstract

Transcription factor (TF) interactions are generally considered to be weak and transient, which enables the dynamic assembly and disassembly of transcription complexes. While advantageous for modulating cellular physiology, requiring rapid adaptation, these characteristics make it challenging to identify and study TF interactions using conventional methodologies. To overcome this issue, we have adapted an ultrasensitive single-molecule array (Simoa) assay, typically used for biomarker detection, to screen for and identify TF-TF interactions. Leveraging Simoa-based digital ELISA, we have screened the human transcription factor library for interaction partners of ARX (aristaless-related homeobox), a transcription factor associated with a wide spectrum of neurodevelopmental disorders. Our successful application of Simoa technology to a high-throughput screening for protein interaction partners opens up new opportunities to study transcription factor-transcription factor interactions, especially those that have been elusive to detect.

PMID:
41143723
Bibliographic data and abstract were imported from PubMed on 27 Oct 2025.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 53
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement